| 标题 |
Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Infectious Diseases 作者:David L Paterson; Helmi Sulaiman; Po-Yu Liu; Mark D Chatfield; Mesut Yilmaz; et al 出版日期:2025 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |